{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-154380","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2024-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.264482+00:00","generated_at":"2026-06-01T06:27:30.810689+00:00","sec_items":["1.01","1.02","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Plus Therapeutics draws $3.3M from Pershing facility to repay Oxford term loan in full","bullets":["Drew $3.3M from Pershing margin loan facility at FOMC target (floor 5.5%) + 1.75% spread + 0.5% fees, max Prime+3%.","On June 3, 2024, used the draw to repay and terminate the Oxford Finance term loan, totaling approx. $3.3M.","Repayment eliminated Oxford's security interest in all of Plus Therapeutics' assets and related covenants.","Pershing credit line is secured by collateralized marketable securities; can draw up to 91.5% of collateral value.","Outstanding balance is due on demand; Pershing may require additional collateral or liquidate securities upon default."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-154380","json":"https://secwatch.observer/filing/0001193125-24-154380.json","markdown":"https://secwatch.observer/filing/0001193125-24-154380.md","text":"https://secwatch.observer/filing/0001193125-24-154380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524154380/0001193125-24-154380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524154380/d840235d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:27:30.810689+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}